US Patent Issued to Massachusetts Institute of Technology, ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA on Feb. 17 for "Selective MENA binding peptides" (Massachusetts, Arizona Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,834, issued on Feb. 17, was assigned to Massachusetts Institute of Technology (Cambridge, Mass.) and ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Ariz.).

"Selective MENA binding peptides" was invented by Theresa Hwang (Cambridge, Mass.), Amy E. Keating (Arlington, Mass.), Meucci Ilunga (Cambridge, Mass.), Sara Parker (Tucson, Ariz.), Ghassan Mouneimne (Tucson, Ariz.) and Samantha Hill (Tucson, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Peptides that selectively bind ENAH (MENA) are described. The peptides are useful for treating certain cancers, such as triple negative breast cancer and for reducing resistance t...